Commonly used measures of acute psychedelic effects (mystical experience, challenging experience, and insight) are now validated in Spanish. An important step toward measuring psychedelic effects in more diverse samples Chris Timmermann Sandeep Nayak Aki Nikolaidis tandfonline.com/doi/full/10.10…

Beautifully said: you can be both pro-psychedelic and anti-hype

How do hallucinogens compare under double-blind conditions? Here's our new Johns Hopkins Psychedelic Research Center paper focusing on the psychological effects of psilocybin and the NMDA-mediated dissociative, dextromethorphan, in healthy volunteers! tinyurl.com/yhspvby7

New CPCR study published! Results from the largest prospective survey of naturalistic psilocybin use show lasting improvements in mental health & well-being 🧵1/7 Sandeep Nayak Nate Sepeda David Mathai, MD Frederick Barrett Justin Strickland Matthew W. Johnson Unlimited Sciences tinyurl.com/bddmh8wf

Our paper on the longitudinal effects of naturalistic psilocybin use is a top trending paper in #psychiatry! Check out the thread of our main study findings x.com/JHPsychedelics… And the paper Frontiers - Psychiatry frontiersin.org/articles/10.33…

Dr. Alan Davis & Nate Sepeda Nate Sepeda published the results of a prospective survey study in American Journal of Drug and Alcohol Abuse (AJDAA) showing combined ibogaine and 5-MeO-DMT assisted therapy can provide robust improvements in mental health functioning, lasting up to 6 months. tandfonline.com/doi/epdf/10.10…

1/12 New paper on psychedelics as treatments for mental health problems! We discuss 10 challenges which limit conclusions that can be drawn about safety/efficacy of psychedelic therapy. We share checklist for journalists, policymakers & others to assess study quality. 🧵

Very cool website, R package, and tutorial paper on preprocessing data from ESM / EMA studies. Website: preprocess.esmtools.com Preprint: osf.io/preprints/psya…

We are seeking individuals with opioid use disorder to participate in a research study looking at the effects of #psilocybin in #OUD. Participants will be treated with buprenorphine and one high dose of psilocybin or placebo. To learn more and apply, visit hopkinspsychedelic.org/opioiduse

Thrilled to present at ISRP this weekend with old friends and new!

Psychedelic experiences have real risks in recreational settings and adverse events can and do occur even in research and clinical contexts. While this information was primary for decades, the press around the positive potential of psychedelics in recent years leads us to issues

The Johns Hopkins Psychedelic Research Center Journal Club is seeking presenters. This is a fantastic opportunity to present original research/ideas on psychedelics and related fields to our group (likeminded in their curiosity but diverse in their backgrounds). Please message if interested!

New NIH NCCIH study launching: Psilocybin and Affective Function in Chronic Low Back Pain and Depression (CLBP+D). Me & Patrick Finan are Co-PIs. CLPB+D is among the leading causes of disability in the US. Now recruiting! Please spread the word and/or send ideas for study recruitment.

In an analysis of our randomized trial of psilocybin assisted therapy for MDD, we found that stronger therapeutic alliance was associated with improvements in depression up to one year later. Additionally, stronger alliance prior to psilocybin administration (after rapport with

We just launched a new psilocybin study for PTSD! We are seeking individuals with Post Traumatic Stress Disorder who are at least 21 years of age to take part in a research study. This study will take place in Baltimore, MD and will investigate whether psilocybin can improve

It’s high time the field of psychedelic research move beyond the mystical experience construct (MEQ). While many critiques of the measure rest on misconceptions, persistent misunderstandings & psychometric limitations lead us to recommend transcending it.

❓ How much do psychedelic guides influence people's hashtag psychedelic experiences in clinical trials? 📢 Next Friday, I'll present some exciting work on the impacts of guides/therapists on people's psychedelic subjective effects.

Our new paper – investigating patterns of change in mental health and substance use before and after naturalistic psilocybin use has been published in the International Journal of Mental Health and Addiction. link.springer.com/article/10.100… / Open: rdcu.be/ejeYa 🧵

We are learning so much from our clinical trial (PI Sandeep Nayak) examining Psilocybin Therapy for PTSD. Here are a few of the areas we're learning about: -How do SSRIs affect the intensity of experience? -What role can trauma-focused psychotherapy play following psilocybin?

Announcing the launch of a new study here at the CPCR! This study will test whether two substances often referred to as psychedelics — psilocybin & MDMA — can address PTSD symptoms and improve quality of life. Participants will receive guided dosing sessions, professional